# MOREPENLAB share price, delivery % and history — Morepen Laboratories Limited

> Delivery percentage for Morepen Laboratories Limited (MOREPENLAB) against its own history, with 7,754 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/MOREPENLAB

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 125.99 INR (6.05% on the day), 2026-09-30
- Delivery: 31.68% of volume taken to demat (20-day average 28.57%)
- Volume: 2.62Cr shares, turnover ₹329.7Cr
- Relative volume: 1.36× of its own 20-day average

## Technicals

- RSI(14): 65.9
- ATR(14): 7.11
- SMA 50: 94.3, SMA 200: 56.18
- 52-week range: 33.05 – 128.1 (-1.65% from the high)

## Performance

- 1 week 2.98%, 1 month 17.57%, 3 months 110.72%
- 6 months 248.52%, 1 year 142.43%

## Delivery percentage

- Latest: 31.68% (2026-09-30)
- 20-day average: 28.57%
- 1-year average: 36.95%
- Percentile against its own history: 22th
- Range: 7.77% – 100% across 1,728 sessions with a reading

Over the last 20 sessions MOREPENLAB settled 28.6% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 36.9%, so recent sessions are running 8.4 points lower than usual. The latest session ranks higher than 22% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 6,903.7 crore
- P/E (TTM): 49.13 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 2.56 INR, split-adjusted to match the price series
- Revenue growth: 34.07% YoY, 17.62% QoQ
- Profit growth: 424.73% YoY, 258.21% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 5.74% | 9.27% |
| 3y | 8.76% | 43.38% |
| 5y | 8.17% | 5.37% |
| 6y | 13.6% | 20.94% |
| 7y | 13.42% | 22.45% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 437.7 | 396.7 | 46 | 34.8 | 0.65 | 7.96% |
| 2024-12-31 | 452.8 | 422.9 | 35.2 | 26.7 | 0.49 | 5.89% |
| 2025-03-31 | 465.9 | 444.8 | 25.7 | 20.3 | 0.35 | 4.36% |
| 2025-06-30 | 425.2 | 414.1 | 15.5 | 10.7 | 0.2 | 2.53% |
| 2025-09-30 | 411.6 | 396.3 | 45.7 | 40.9 | 0.75 | 9.93% |
| 2025-12-31 | 484.2 | 452.5 | 35.4 | 27.5 | 0.5 | 5.68% |
| 2026-03-31 | 484.7 | 469.9 | 23.3 | 15.7 | 0.28 | 3.25% |
| 2026-06-30 | 570.1 | 500.8 | 74.5 | 56.4 | 1.03 | 9.89% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 35.65%
- Public: 64.35%
- FII: 1.46%, DII: 1.28%
- Promoter shares pledged: 0%

## Recent filings

- 2026-09-18: dividend
- 2026-08-04: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_182122_04082026161956_iXBRL_WEB.html
- 2026-07-13: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1691578_13072026052444_WEB.xml
- 2026-05-26: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_161456_26052026184320_iXBRL_WEB.html
- 2026-04-10: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1648754_10042026040736_WEB.xml
- 2026-02-10: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141555_10022026162334_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1599549_13012026014919_WEB.xml
- 2025-11-14: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127935_14112025165902_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 118 events are indexed for this instrument.

## About the instrument

- Listed: 1995-05-15 — latest session 2026-09-30 (7,754 sessions)
- ISIN: INE083A01026
- Series: EQ
- Liquidity rank: #121 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/MOREPENLAB.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.